Life Science News and Press Releases

Merck Millipore Launches CpGenome™ Direct Prep Bisulfite Modification Kit for Simplified One-Step Conversion of Unmethylated Cytosines

Merck Millipore

23/10/2013

• Eliminates the need to isolate genomic DNA prior to performing bisulfite analysis • Conversion efficiencies are >99.5% from as few as 10 cells or as low as 50 pg of DNA• Suitable for downstream analysis by methylation specific PCR, restriction digestion, sequencing and microarray hybridization October 23, 2013, Darmstadt, Germany - Merck Millipore, the Life Science division of Merck, ...

Merck Millipore Introduces the First Online Original Manufacturer Tracking Tool

Merck Millipore

23/10/2013

Merck Millipore has launched the industry's first online tool for tracking the original manufacturer of nearly 4000 materials for pharmaceutical raw ingredients including excipients, biopharm ingredients, and APIs. The electronic Original Manufacturer Tracking (eOMT) saves users valuable time in research and enables compliance with regulatory requirements. Prior to availability of the eOMT tool, the original manufacturer had to be researched manually via a...

Merck Millipore to be Global Distributor for SmartRNAplex™ MicroRNA Profiling Assay

Merck Millipore

16/10/2013

• Enables high throughput, multiplexed microRNA analysis for up to 68 targets and 96 samples in one assay• Works with a wide range of sample types including serum, plasma, crude cell digests and formalin-fixed tissues • Based on Firefly™ technology from Firefly BioWorks October 16, 2013, Darmstadt, Germany - Merck Millipore, the Life Science division of Merck, today announced they have entered...

Merck Millipore Launches Eshmuno® A Chromatography Media and Chromabolt™ Prepacked Columns

Merck Millipore

17/09/2013

• Eshmuno® A is a rigid, high capacity, acid and alkaline resistant Protein A affinity chromatography media• Chromabolt™ is a family of prepacked, pre-validated chromatography columns available in 10, 20, and 32 cm i.d. packed with Merck Millipore resins for use in pilot and early clinical manufacturing September 17, 2013, Darmstadt, Germany - Merck Millipore, the Life Science division of Merck, today introduced two...

Merck Millipore Adds Human Recombinant Ataxia Telangiectasia Mutated (ATM) Enzyme to Comprehensive Kinase Enzyme Portfolio

Merck Millipore

21/08/2013

• ATM plays a key role in events following DNA damage and, as such, is an important drug target • Recombinantly expressed ATM available at pharmaceutical-grade yield, purity and activity• Part of the 400+ Upstate® enzyme portfolio and the KinaseProfiler™ fee-for-service testing panelAugust 21, 2013, Darmstadt, Germany - Merck Millipore, the Life Science division of Merck, has added the ataxia...

Merck Millipore Partners with Gyros to Develop, Manufacture and Commercialize Kits on the Gyrolab™ Immunoassay Platform

Merck Millipore

15/07/2013

• Simple, automated, nanoliter-scale assays requiring as little as 1uL of sample• Ready-to-use kits are fully validated for reliable use in clinical research• Accuracy and precision meet or exceed ELISA performance July 15, 2013, Darmstadt, Germany - Merck Millipore, the Life Science division of Merck, today announced a partnership with Gyros AB to develop, manufacture and commercialize immunoassay...

Merck Millipore Launches Cellvento™ CHO-200 Chemically Defined Cell Culture Medium for Consistent High Performance in Fed-Batch Mode

Merck Millipore

24/06/2013

• Cellvento™ CHO-200 medium and complementary feeds provide efficient fed-batch culture• Delivers robust cell growth and high productivity • Backed by Merck Millipore's deep regulatory expertise in pharmaceutical raw materials June 24, 2013, Darmstadt, Germany - Merck Millipore, the Life Science division of Merck, today launched Cellvento™ CHO-200 chemically defined cell...

Merck Millipore Launches PluriSTEM™ Human ES/iPS Medium for the Expansion of Human Embryonic and Induced Pluripotent Stem Cells

Merck Millipore

13/06/2013

• Enables routine expansion of cells in feeder-free and serum-free conditions• Supports less frequent feeding and cell culture time, saving time and research costs• Supports efficient single cell passaging of human ES/iPS cells• Includes small molecule inhibitors, pluripotent specific growth factors, and supplements June 12, 2013, Darmstadt, Germany - Merck Millipore, the Life...